Information  X 
Enter a valid email address

PureTech Health PLC (PRTC)

  Print      Mail a friend

Tuesday 07 July, 2015

PureTech Health PLC

Holding(s) in Company

RNS Number : 4191S
PureTech Health PLC
07 July 2015
 



 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

PureTech Health Plc

Sedol BY2Z0H7

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights


 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


 

An event changing the breakdown of voting rights

 

Other (please specify):



 

3. Full name of person(s) subject to the
notification obligation:
iii

1Lansdowne Partners International Limited

2Lansdowne Partners Limited

3Lansdowne Partners (UK) LLP

 

4. Full name of shareholder(s)
 (if different from 3.):iv

Vidacos Nominees Ltd.

(Registered Shareholder)

 

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

03/07/2015

 

6. Date on which issuer notified:

07/07/2015

 

7. Threshold(s) that is/are crossed or
reached:
vi, vii

 

5%

 

 



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares

11,850,000

5.21%



11,850,000


 4.99%

GB00BY2Z0H74


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 






Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

11,850,000

4.99%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

Lansdowne Partners International Limited is the parent undertaking of Lansdowne Partners Limited which is the First Corporate Member of Lansdowne Partners (UK) LLP.


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:

 

Based on ordinary shares in issue of 237,387,951. This disclosure results from new shares issued by the Company on 3rd July 2015 and is not a result of any trading activity.

 

14. Contact name:

Liz Kaskela

15. Contact telephone number:

+44(0)20 7290 5500

 

 

 

 

 

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLRRMITMBBMBBA

a d v e r t i s e m e n t